Decibel Therapeutics (DBTX) Stock Highlights

4.91 | +0%

2023-10-26 20:57:28

Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. Its lead gene therapy product candidate is DB-OTO which provides hearing to individuals born with profound hearing loss due to an OTOF deficiency. The firms pipeline products comprise DB-ATO, AAV.103, AAV.104, AAV.201, DB-020, and Cochlear Hair Cell Regeneration.

Statistics

Range Today

4.91 4.91

Volume Today 0

Range 1 Year

1.61 5.4

Volume 1 Year 25.9M

Range 3 Year

1.61 24.39

Volume 3 Year 74.97M

Range 10 Year

1.61 24.39

Volume 10 Year 74.97M

Highlights

Market Capitalization 128.65M (small)

Floating Shares 13.34M

Current Price 4.91

Price To Earnings -1.98

Price To Book 2.41

Earnings Per Share -2.55

Payout Ratio 0%

Performance

Latest 0%

1 Month -3.16%

3 Months +37.15%

6 Months +54.89%

1 Year +43.99%

3 Years -76.84%

5 Years -76.84%

10 Years -76.84%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.